• Technology
    • First Access Challenge
    • Resources
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Blog
  • Contact
Nautilus Biotechnology
  • Technology
    • First Access Challenge
    • Resources
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • IR Resources
  • Blog
  • Contact

 

Company

 

Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome. We are driven to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across biomedical research and drug discovery.

 

We were founded in 2016 on the belief that incremental advancements to existing technologies are inadequate; that a bold scientific leap would be required to radically reinvent proteomics and create a new gold standard in the field.

 

Our mission is to integrate our breakthrough innovations in computer science, engineering, and biochemistry to develop a protein analysis platform of extreme sensitivity and scale. Pursuing that goal is a leadership team with a unique combination of experiences from the fields of technology and life sciences, and a broader team made up of a wide spectrum of disciplines and expertise including protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticians, and software engineers.

 

Nautilus exists to pursue deep, hard science and, ultimately, to positively impact the health of millions around the world.

Leadership

Sujal Patel
Founder & CEO

Sujal Patel

Founder & CEO

Sujal Patel is a successful technology entrepreneur and executive who founded and served as CEO of Isilon Systems, an enterprise data storage company. In 2006, Isilon completed one of the most successful initial public offerings of the year. Isilon was acquired by EMC in 2010 for $2.6 Billion, the largest acquisition in EMC’s history. Sujal served as the President of EMC’s Isilon Storage Division from the acquisition until 2012, driving significant revenue growth, market expansion and organizational scale. He graduated from the University of Maryland College Park in 1996 with a degree in Computer Science.

Parag Mallick, PhD
Founder & Chief Scientist

Parag Mallick, PhD

Founder & Chief Scientist

Dr. Parag Mallick is an Associate Professor at Stanford University, and an interdisciplinary scientist, who has developed multi-scale approaches to accelerate the discovery of diagnostic and prognostic protein biomarkers. Parag trained with pioneering researcher Ruedi Aebersold in clinical proteomics and systems biology at the Institute for Systems Biology. Parag holds a BS degree in Computer Science from Washington University in St. Louis, and a PhD in Chemistry & Biochemistry from UCLA. He has over 75 publications and holds patents in the fields of artificial intelligence, proteomics technology, biomarker development, and nanotechnology.

Anna Mowry
Chief Financial Officer

Anna Mowry

Chief Financial Officer

Anna is an experienced finance and business leader who joins Nautilus from Igneous where she served as VP of Finance and Operations with responsibility for finance, accounting, people, legal, and operations. Previously, Anna held a variety of roles at companies including Amazon Web Services and Isilon Systems, where she ultimately led the finance and sales operations organization. Anna has a BS in Biochemistry from Western Washington University and started her career at the Fred Hutchinson Cancer Research Institute. She earned her MBA from the University of Washington, leading her into a variety of finance and business roles of escalating responsibility.

Nick Nelson
Chief Business Officer

Nick Nelson

Chief Business Officer

Nick Nelson has extensive leadership experience with top-tier diagnostics, therapeutics and life science companies. Before joining Nautilus, he was Chief Business Officer at Caris Life Sciences where he led all business development and strategic partnerships. Prior to Caris, he was Vice President of Commercial and Corporate Development at Trovagene (now Cardiff Oncology), and before that spent ten years at Illumina. While at Illumina he held leadership positions in the New and Emerging Markets business where he established partnerships and collaborations enabling high-growth genomics businesses. He received his Bachelor of Science degree in Cellular and Molecular Biology from San Diego State University.

Gwen Weld
Chief People Officer

Gwen Weld

Chief People Officer

Gwen has more than 25 years of senior leadership in human resources, organizational culture, and business strategy. She previously held the positions of Vice President of Global People and Infrastructure at Isilon Systems for more than six years and General Manager of Human Resources at Microsoft Corporation for nearly twenty years, leading Microsoft’s human resources agenda for its various groups and overseeing worldwide recruiting and alternative staffing. Ms. Weld studied business administration at Pace University.

Mary Godwin
SVP of Operations

Mary Godwin

SVP of Operations

Mary Godwin is a proven Operations and Supply Chain executive with deep experience across large corporations and smaller start ups. She brings to Nautilus deep experience developing processes and business relationships that improve both corporate metrics and financial performance. Before joining Nautilus, Mary held similar roles at Qumulo and Isilon Systems, where she built and scaled an operations function that supported over $1B in annual revenue. Prior experience included senior operational roles at Apple, Philips Electronics, and Lucent Technologies. She holds a Bachelor of Science degree in Plastics Engineering from the University of Massachusetts Lowell, and an MBA from Santa Clara University.

Subra Sankar, PhD
SVP of Product Development

Subra Sankar, PhD

SVP of Product Development

Subra is a seasoned product and engineering leader who joins Nautilus from GenapSys where he served as SVP of Product Development, leading the company’s R&D efforts including Engineering, Assay, System Integration, Consumable Development, Informatics and a variety of chemistry and molecular biology groups. Subra has held many senior roles over the last 15 years, notably at Solexa/Illumina where, from 2006 to 2012, he led instrument and consumable development efforts for next gen sequencers and related products. Subra has a Ph.D. in Aerospace Engineering from Georgia Tech and an MBA from UC Berkeley.

Matthew Murphy, Esq.
General Counsel

Matthew Murphy, Esq.

General Counsel

Matt has spent over a quarter century advising companies on the cutting edge of life sciences technologies. He has held numerous General Counsel roles over this period, including most notably at Pacific Biosciences and 10X Genomics. He specializes in creating and defending industry defining patent portfolios, and in building and leading legal operations that help develop, finance and commercialize high growth companies. Matt received his Bachelor of Science in Microbiology and Fermentation Science from the University of California, Davis, and a Juris Doctorate from the University of San Francisco School of Law.

Chris Blessington
VP of Corp Marketing & Comms

Chris Blessington

VP of Corp Marketing & Comms

Chris is a proven marketing leader who joins Nautilus from Smartsheet where he served as VP of Marketing and Communications with responsibility for creating markets, building awareness, and driving revenue. Prior to that, he led marketing and communications at ExtraHop Networks and Isilon Systems through the company’s acquisition by EMC. At EMC/Isilon, he served as executive sponsor of the company’s Life Sciences and Genomics markets, leading product evangelism, market research, and sales preparedness. Chris holds a BS from Syracuse University.

Ken Kuhn, PhD
VP of Reagent and Platform Development

Ken Kuhn, PhD

VP of Reagent and Platform Development

An experienced R&D, product development, and operations executive, Dr. Kuhn served as Vice President of Systems Integration, Product Development and Operations, at Encodia and as Senior Director of Product Development at Illumina, where he played a significant early role in developing and commercializing a range of NGS, genotyping, gene expression, and qPCR systems. Dr. Kuhn holds a Ph.D. in microbiology and immunology from Stanford University and a B.S. in biochemistry and molecular biology from Drexel University.

Sheri Wilcox, PhD
VP of Affinity Reagent Development

Sheri Wilcox, PhD

VP of Affinity Reagent Development

Sheri spent 21 years at SomaLogic where she was instrumental in the development of the SomaScan Platform and SOMAmer reagents. As Associate Director of Aptamer Discovery she guided research of aptamers for biomarker discovery and directed the high-throughput generation of SOMAmer reagents, and as Senior Director of Analytical and Discovery Sciences, led SOMAmer discovery and characterization efforts, as well as several collaborations. Before joining SomaLogic, she was a postdoctoral fellow at Pharmacia, prior to its merger with Pfizer Inc. Dr. Wilcox received her B.S. in chemistry from Vanderbilt University, and her Ph.D. in macromolecular and cellular structure and chemistry from Scripps Research.

Board of Directors

Matt Posard
Board Chair, Founding Principal, Explore DNA

Matt Posard

Board Chair, Founding Principal, Explore DNA

Former SVP & Head of Sales, Illumina

Karen Akinsanya
President of R&D, Therapeutics, Schrödinger

Karen Akinsanya

President of R&D, Therapeutics, Schrödinger

Michael Altman
Managing Director, Perceptive Advisors

Michael Altman

Managing Director, Perceptive Advisors

Melissa Epperly
CFO, Zentalis Pharmaceuticals

Melissa Epperly

CFO, Zentalis Pharmaceuticals

Parag Mallick, PhD
Founder, Chief Scientist

Parag Mallick, PhD

Founder, Chief Scientist


Matt McIlwain
Managing Director, Madrona Venture Group

Matt McIlwain

Managing Director, Madrona Venture Group

Farzad Nazem
Former EVP Engineering & CTO, Yahoo

Farzad Nazem

Former EVP Engineering & CTO, Yahoo

Vijay Pande, PhD
General Partner, Andreessen Horowitz

Vijay Pande, PhD

General Partner, Andreessen Horowitz

Sujal Patel
Founder, Chief Executive Officer

Sujal Patel

Founder, Chief Executive Officer

Scientific Advisory Board

Ruedi Aebersold, PhD

Ruedi Aebersold, PhD

Professor of Systems Biology
Institute of Molecular Systems Biology in ETH Zurich (IMSB) ​

  • Pioneer in the field ​of proteomics​
  • Co-founder of several companies and head of the biology/disease branch of ​the human proteome project
Lee Hartwell, PhD

Lee Hartwell, PhD

President and Director Emeritus
Fred Hutchinson Cancer Research Center​

  • Discovered protein ​molecules that control ​the division of cells​
  • 2001 Co-recipient ​Nobel Prize in ​Physiology and Medicine
Joshua LaBaer, ​MD, PhD

Joshua LaBaer, ​MD, PhD

Executive Director
Biodesign Institute at Arizona State University​

  • Leading researcher in cancer and personalized medicine​
  • Inventor of the novel protein microarray technology, ​Nucleic Acid Programmable Protein Array (NAPPA), ​which has been used widely ​for biomedical research
Emma Lundberg, PhD

Emma Lundberg, PhD

Director
Cell Atlas of the Human Protein Atlas

  • Professor in cell biology proteomics at KTH Royal Institute of Technology, Sweden
  • Pioneer in the field of spatial proteomics
  • Advocate of citizen science, advancing the use of gaming for science and health applications

Sign-up For Updates









    Nautilus Biotechnology

     

    Corporate Headquarters
    2701 Eastlake Avenue East
    Seattle, WA 98102

     

    Research Headquarters
    835 Industrial Road, Suite 200
    San Carlos, CA 94070

     

         

    +1 (206) 333-2001

    © 2022 Nautilus Biotechnology Inc.
    All Rights Reserved.

    Privacy Policy | Terms of Use

    We use cookies in order to continually improve your experience on our website. By clicking “Accept cookies” or clicking on any content on our site, you are consenting to our use of cookies as described in our Privacy Policy. You can opt-out if you wish. Accept Reject All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT